IGF2BP2 and neoplasm: For example, as the m6A writers, methyltransferase‐like 3 (METTL3) has been identified to promote CRC progression by maintaining the expression of SOX2 via an m6A‐IGF2BP2‐dependent manner,10 while METTL14 acts as a tumour suppressor and promotes lncRNA XIST and SOX4 mRNA methylation to attenuate their expression through YTHDF2‐mediated RNA decay.11, 12